Labeling decisions shape everything that follows a drug's approval: how it's marketed, how it's prescribed, and how exposed a company is to regulatory and commercial risk. Yet most regulatory labeling services still run on manual searches, static PDFs, and disconnected databases that can't keep pace with a global label landscape that changes daily. Dr. Evidence replaces that patchwork with a single pharma label intelligence platform: validated global data, AI-powered comparison, and automated monitoring built specifically for the teams who live inside the label, from first submission through years of commercialization.
Regulatory affairs and labeling teams at established biopharma companies rely on Dr. Evidence to move faster through Target Product Profile and Company Core Data Sheet development without sacrificing precision. Emerging biopharma teams preparing their first global submissions use the platform to understand precedent label language before a single meeting with a health authority. And regulatory operations teams at generics companies depend on it to track brand-leader labels, protecting their portfolios from the kind of oversight that manual monitoring often can't catch.
Book a Demo
Dr. Evidence gives your team direct access to approved labels from major geographies around the world, covering both prescription and non-prescription products.
Instead of chasing down documents market by market, your team works from contemporary, updated data and streamlined workflows that support Target Product Profile and Target Label Profile development, Company Core Data Sheet preparation, and health authority negotiation planning, all from one authoritative source.
This is what regulatory labeling software should have been from the start: global, current, and built around how labeling teams actually work.
Every labeling strategy conversation eventually comes down to a comparison. This label versus that one, this market versus that market, this version versus the last. Dr. Evidence's pharma label comparison services generate side-by-side comparisons instantly, so your team can identify key differences between label versions and review adverse events across labels in minutes, not days. That speed directly informs and accelerates label strategy at every stage.
Behind every comparison is Human-in-Command AI: a summarized view of label differences, precise identification of true indications that eliminates the noise of contraindications, and a detailed adverse event comparison view your team can trust. This is drug label intelligence built for a regulated industry, not adapted from general-purpose AI.
For generics teams, manually monitoring brand leader labels takes significant time and exposes entire portfolios to avoidable risk. A missed label update isn't a small oversight. It can mean regulatory enforcement exposure, commercial disruption, or a scramble to catch up on changes that should have triggered an immediate response. Dr. Evidence's automated reference listed drug (RLD) monitoring tracks RLD labels and sends automatic notifications when label content changes, so your team is never caught reacting to something it should have seen coming.
Before a draft label goes anywhere near a health authority, it needs to be tested against the market it's entering. Dr. Evidence lets your team upload draft labels directly in-platform and compare them section-by-section against on-market RLD labels, surfacing gaps, inconsistencies, and opportunities before they become costly. For teams navigating skinny labeling and Orange Book strategy, the platform supports analysis of relevant regulatory approval packages and patent review for covered uses and indications, helping identify the specific narrow language a submission requires. It's pharma label intelligence applied at the most consequential stage of the process: before the label is final.
Biopharma teams use Dr. Evidence to accelerate their drug label analysis. Not incremental improvement, but a fundamentally faster way of working.
Book a Demo to see Dr. Evidence's pharma labeling software in action to see exactly how it works.